Ubs Asset Management Americas Inc Nuvalent, Inc. Transaction History
Ubs Asset Management Americas Inc
- $446 Billion
- Q3 2025
A detailed history of Ubs Asset Management Americas Inc transactions in Nuvalent, Inc. stock. As of the latest transaction made, Ubs Asset Management Americas Inc holds 65,417 shares of NUVL stock, worth $6.31 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
65,417
Previous 169,539
61.41%
Holding current value
$6.31 Million
Previous $12.9 Million
56.27%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding NUVL
# of Institutions
210Shares Held
61.3MCall Options Held
35.1KPut Options Held
62.2K-
Deerfield Management Company, L.P. (Series C) New York, NY18MShares$1.74 Billion28.96% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY5.27MShares$509 Million14.68% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.61MShares$444 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.02MShares$292 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA2.3MShares$222 Million0.04% of portfolio
About Nuvalent, Inc.
- Ticker NUVL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 42,977,800
- Market Cap $4.15B
- Description
- Nuvalent, Inc., a clinical stage biopharmaceutical company, develops therapies for patients with cancer. Its lead product candidates are NVL-520, a brain-penetrant ROS1-selective inhibitor to inhibit ROS1 fusions that express the normal ROS1 kinase domain without any drug-resistant mutations and remain active in the presence of mutations conferr...